乙肝康治疗慢性乙型肝炎近期疗效分析
投稿时间:2003-11-26    点此下载全文
引用本文:张夏华,龚守军,吴征.乙肝康治疗慢性乙型肝炎近期疗效分析[J].药学实践杂志,2004,(3):148~149
摘要点击次数: 1094
全文下载次数: 1472
作者单位
张夏华 武警上海总队医院, 上海 201103 
龚守军 武警上海总队医院, 上海 201103 
吴征 武警上海总队医院, 上海 201103 
中文摘要:目的 评价中药复合制剂乙肝康对慢性乙型肝炎治疗作用。方法 选择HBeAg、HBV-DNA阳性,肝功能异常的31例慢性乙型肝炎作治疗对象,给予乙肝康10mL加入5%葡萄糖250mL内每日滴注1次,疗程3个月,并与25例静滴甘利欣,泰特病人作对照。结果 完全应答11例,部分应答13例,无应答7例。HBV-DNA14例阴转(45.1%),HBeAg11例阴转(35.5%),其中 9例HBeAg/抗HBe血清转换(29%)。结论 乙肝康具有治疗慢性乙型肝炎肝功能的作用,同时具有清除体内病毒的作用,值得进一步研究。
中文关键词:乙肝康  慢性乙型肝炎  疗效
 
The clinical therapeutic outcomes of Yigankang in treatment of chronic hepatitis B patients
Abstract:Objective To evaluate the clinical therapeutic outcomes of Yigankang in treatment chronic hepatitis B patients.Methods 31 patients with HBeAg(+),HBV-DNA(+)were treated by routine therapy with Yigankang for 3 months,and 25 patients as control were investigated meantime.Results The serum HBeAg negative conversion rate was 35.5% and the serum HBV-DNA negative was 45.1% after treatment.The serum HBeAg and HBeAb conversion rate was 29%.Conclusion Yigankang can improve the liver function of chronic hepatitis B,and it can eliminate HBV.
keywords:Yigankang  chronic hapatitis B  efficacy
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮